China approves CARsgen's CAR-T treatment for stomach cancer
- Posted on June 22, 2026
- By Bing News
- 0 Views
- 1 min read
China approves CARsgen's CAR-T treatment for stomach cancer
SHANGHAI, June 22 (Reuters) - China's drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients' immune cells to recognise and kill cancer cells. The injection, also known as satri-cel, is globally the first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai told Reuters in an
